374 related articles for article (PubMed ID: 12580919)
61. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
62. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
[TBL] [Abstract][Full Text] [Related]
63. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy.
Schülke S; Burggraf M; Waibler Z; Wangorsch A; Wolfheimer S; Kalinke U; Vieths S; Toda M; Scheurer S
J Allergy Clin Immunol; 2011 Dec; 128(6):1340-1348.e12. PubMed ID: 21872305
[TBL] [Abstract][Full Text] [Related]
64. Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasma gondii-derived heat shock protein 70.
Mun HS; Aosai F; Norose K; Piao LX; Fang H; Akira S; Yano A
Infect Immun; 2005 Aug; 73(8):4634-42. PubMed ID: 16040976
[TBL] [Abstract][Full Text] [Related]
65. Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release.
Netea MG; Kullberg BJ; Jacobs LE; Verver-Jansen TJ; van der Ven-Jongekrijg J; Galama JM; Stalenhoef AF; Dinarello CA; Van der Meer JW
J Immunol; 2004 Jul; 173(2):1477-82. PubMed ID: 15240744
[TBL] [Abstract][Full Text] [Related]
66. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
Shi S; Blumenthal A; Hickey CM; Gandotra S; Levy D; Ehrt S
J Immunol; 2005 Sep; 175(5):3318-28. PubMed ID: 16116224
[TBL] [Abstract][Full Text] [Related]
67. Synergistic effects of lipopolysaccharide and interferon-gamma in inducing interleukin-8 production in human monocytic THP-1 cells is accompanied by up-regulation of CD14, Toll-like receptor 4, MD-2 and MyD88 expression.
Tamai R; Sugawara S; Takeuchi O; Akira S; Takada H
J Endotoxin Res; 2003; 9(3):145-53. PubMed ID: 12831455
[TBL] [Abstract][Full Text] [Related]
68. Priming of human oral epithelial cells by interferon-gamma to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans.
Uehara A; Sugawara S; Takada H
J Med Microbiol; 2002 Aug; 51(8):626-634. PubMed ID: 12171292
[TBL] [Abstract][Full Text] [Related]
69. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans.
Quesniaux VJ; Nicolle DM; Torres D; Kremer L; Guérardel Y; Nigou J; Puzo G; Erard F; Ryffel B
J Immunol; 2004 Apr; 172(7):4425-34. PubMed ID: 15034058
[TBL] [Abstract][Full Text] [Related]
70. MyD88-dependent toll-like receptor signalling is not a requirement for fetal islet xenograft rejection in mice.
Schmidt P; Krook H; Goto M; Korsgren O
Xenotransplantation; 2004 Jul; 11(4):347-52. PubMed ID: 15196129
[TBL] [Abstract][Full Text] [Related]
71. Toll-like receptors as key mediators in innate antifungal immunity.
Roeder A; Kirschning CJ; Rupec RA; Schaller M; Weindl G; Korting HC
Med Mycol; 2004 Dec; 42(6):485-98. PubMed ID: 15682636
[TBL] [Abstract][Full Text] [Related]
72. Toll-like receptors control activation of adaptive immune responses.
Schnare M; Barton GM; Holt AC; Takeda K; Akira S; Medzhitov R
Nat Immunol; 2001 Oct; 2(10):947-50. PubMed ID: 11547333
[TBL] [Abstract][Full Text] [Related]
73. Class A dioscorins of various yam species suppress ovalbumin-induced allergic reactions.
Yang CC; Lin KC
Immunopharmacol Immunotoxicol; 2014 Jun; 36(3):242-9. PubMed ID: 24852318
[TBL] [Abstract][Full Text] [Related]
74. Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity.
van Zijverden M; van der Pijl A; Bol M; van Pinxteren FA; de Haar C; Penninks AH; van Loveren H; Pieters R
Toxicol Appl Pharmacol; 2000 Oct; 168(2):131-9. PubMed ID: 11032768
[TBL] [Abstract][Full Text] [Related]
75. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
[TBL] [Abstract][Full Text] [Related]
76. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways.
Sato S; Takeuchi O; Fujita T; Tomizawa H; Takeda K; Akira S
Int Immunol; 2002 Jul; 14(7):783-91. PubMed ID: 12096038
[TBL] [Abstract][Full Text] [Related]
77. Toll-like receptors and other links between innate and acquired alloimmunity.
Goldstein DR
Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
[TBL] [Abstract][Full Text] [Related]
78. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
Gohda J; Matsumura T; Inoue J
J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
[TBL] [Abstract][Full Text] [Related]
79. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
80. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
